Dr. med. Fabienne Iten

Wissenschaftliche Publikationen

Depner C, Erba P, Rieger UM, Iten F, Schaefer DJ, Haug M. Donor-site morbidity of the sensate extended lateral arm flap.  J Reconstr Microsurg. 2012 Feb;28(2):133-8. doi: 10.1055/s-0031-1289165. Epub 2011 Sep 29.

Walter MA, Meier C, Radimerski T, Iten F, Kränzlin M, Müller-Brand J, de Groot JW, Kema IP, Links TP, Müller B. Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer.  Cancer. 2010 Jan 1;116(1):31-40. doi: 10.1002/cncr.24738.

Iten F, Muller B, Schindler C, Rasch H, Rochlitz C, Oertli D, Maecke HR, Muller-Brand J, Walter MA. [(90)Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer: long-term results of a phase 2 clinical trial.  Cancer. 2009 May 15;115(10):2052-62. doi: 10.1002/cncr.24272.

Iten F, Müller B, Schindler C, Rochlitz C, Oertli D, Mäcke HR, Müller-Brand J, Walter MA. Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial.  Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6696-702.